EUVIMEDEUVIMED entdecken
Klinische Studie (Phase II)Open Access

Psychological Impact of Analytical Treatment Interruption on Young Women Enrolled in an HIV Cure-Related Clinical Trial in Durban, South Africa

Ali Ahmed, Krista L Dong, Maryam Hussain, Mzwakhe Wiseman Ngcobo, Ntombifuthi Langa, Ayanda Zulu, Luyanda Maphalala, Vanessa Pillay, Maud Mthembu, Fang Wan, Whitney Tran, Rachel Lau und 3 weitere

AIDS Research and Human Retroviruses · 01.03.2026 · 42 (3) · 109-116

DOI: 10.1177/08892229251405807 ↗

Kurz gefasst

Klinische Studie (Phase II) in der Zeitschrift AIDS Research and Human Retroviruses, online erschienen am 02.01.2026. Verfasst von Ali Ahmed und 14 weiteren Autor:innen. Beteiligte Einrichtung: Division of Infectious Diseases and Global Public Health, School of Medicine, University of California San Diego (UCSD), La Jolla, California, USA. Hauptthemen laut MEDLINE: HIV Infections, Anti-HIV Agents. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Gates Foundation, NIAID NIH HHS, NIMH NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Analytical treatment interruption (ATI) is a planned and monitored pause of ART used in HIV-related studies that enables measurement of viral rebound kinetics and immune responses, yet it may pose psychological risks to participants. Evidence has largely come from predominantly male cohorts in high-income settings; far less is known about how women living with HIV (WLHIV) in Southern Africa experience ATIs. We conducted a longitudinal sociobehavioral study nested within an ATI-inclusive Phase 2A clinical trial occurring in Durban, South Africa (NCT05281510). Twenty WLHIV who initiated ART during acute HIV and who were enrolled in an ATI clinical trial agreed to participate in this sociobehavioral research study. Participants completed validated psychological assessments at baseline (T1), pre-ATI (T2), post-ATI (T3), and end of clinical trial (T4). Outcomes included decisional certainty, self-esteem, resilience, anxiety, and depression; analyses were descriptive and stratified by time to ART restart: early restart (ER; 44 weeks, n = 6). Median decisional certainty increased from T1 4.70 (IQR 0.80) to T4 5.00 (0.00). Self-esteem remained high (T1 24.5; T4 26.0), with the largest gains in the DR group. Resilience was stable (median 4.75–4.50), rising modestly among participants in the LTDR group. Anxiety peaked pre-ATI (T2 33.3 [11.5]) then declined, except in the LTDR group, and anxiety and depression remained high (T4 anxiety 31.0; depression 8.0). ATI was well-tolerated across measures, anxiety spiked only pre-ATI and subsided, except in the LTDR group, where prolonged ATI kept both anxiety and depression elevated. These findings support the inclusion of South African WLHIV in ATI-inclusive clinical trials and highlight the need for psychosocial support for clinical trial participants.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HIV InfectionsAnti-HIV AgentsHumansFemaleSouth AfricaAdultLongitudinal StudiesYoung AdultDepressionAnxietySelf ConceptTreatment Interruption

Stichwörter der Autor:innen

HIV cure researchanalytical treatment interruptionanxietydecisional certaintydepressionmental healthresilienceself-esteem

Substanzen

Anti-HIV Agents

Autor:innen und Institutionen

  • Division of Infectious Diseases and Global Public Health, School of Medicine, University of California San Diego (UCSD), La Jolla, California, USA.
  • Ragon Institute of Mass General Brigham, MIT and Harvard, Cambridge, Massachusetts, USA.
  • MGH, Boston, Massachusetts, USA.
  • Harvard Medical School, Cambridge, Massachusetts, USA.
  • Integration of TB in Education and Care for HIV/AIDS (ITEACH), Pietermaritzburg, South Africa.
  • Females Rising through Education, Support and Health (FRESH), Durban, South Africa.

ORCID-Profile: Karine Dubé

Förderung

  • Gates Foundation
  • NIAID NIH HHS
  • NIMH NIH HHS
  • Wellcome Trust
  • National Institute of Allergy and Infectious Diseases
  • National Institute of Mental Health

Zitieren

APA

Ahmed, A., Dong, K. L., Hussain, M., Ngcobo, M. W., Langa, N., Zulu, A., Maphalala, L., Pillay, V., Mthembu, M., Wan, F., Tran, W., Lau, R., Stockman, J. K., Ndung'u, T., & Dubé, K. (2026). Psychological Impact of Analytical Treatment Interruption on Young Women Enrolled in an HIV Cure-Related Clinical Trial in Durban, South Africa. AIDS Research and Human Retroviruses, 42(3), 109-116. https://doi.org/10.1177/08892229251405807

Vancouver

Ahmed A, Dong KL, Hussain M, Ngcobo MW, Langa N, Zulu A, et al. Psychological Impact of Analytical Treatment Interruption on Young Women Enrolled in an HIV Cure-Related Clinical Trial in Durban, South Africa. AIDS Research and Human Retroviruses. 2026;42(3):109-116. doi:10.1177/08892229251405807

BibTeX
@article{Ahmed2026,
  author = {Ahmed, Ali and Dong, Krista L and Hussain, Maryam and Ngcobo, Mzwakhe Wiseman and Langa, Ntombifuthi and Zulu, Ayanda and Maphalala, Luyanda and Pillay, Vanessa and Mthembu, Maud and Wan, Fang and Tran, Whitney and Lau, Rachel and Stockman, Jamila K and Ndung'u, Thumbi and Dubé, Karine},
  title = {Psychological Impact of Analytical Treatment Interruption on Young Women Enrolled in an HIV Cure-Related Clinical Trial in Durban, South Africa},
  journal = {AIDS Research and Human Retroviruses},
  year = {2026},
  volume = {42},
  number = {3},
  pages = {109--116},
  doi = {10.1177/08892229251405807}
}
Kostenlos starten →